TITLE

Antiviral Briefs

PUB. DATE
February 2010
SOURCE
AIDS Patient Care & STDs;Feb2010, Vol. 24 Issue 2, p133
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information on research studies related to treatments for viral diseases. A new study finds that highly active antiretroviral therapy (HAART) is associated with lower health care costs and improved health outcomes. Specifically, antiretroviral adherence produces a net overall median monthly health care cost of 85 dollar per patient. Researchers from the UCLA AIDS Institute in Los Angeles, California have demonstrated that human blood stem cells can be engineered into cells capable of targeting and killing HIV-infected cells. Harvard School of Public Health researchers have found that powerful antiretroviral therapy combinations decrease the average death rate HIV-infected patients by half over an average of 3 years.
ACCESSION #
48112136

 

Related Articles

  • A Review of Economic Evaluations of Darunavir Boosted by Low-Dose Ritonavir in Treatment-Experienced Persons Living with HIV Infection. Mauskopf, Josephine; Annemans, Lieven; Hill, Andrew M.; Smets, Erik // PharmacoEconomics;2010 Supplement, Vol. 28, p1 

    Darunavir boosted by low-dose ritonavir (DRV/r), at a daily dose of 600/100mg twice a day (bid), has been shown to be superior to alternative highly active antiretroviral therapy (HAART) regimens for the management of treatment-experienced, HIV-infected adults in the phase IIb POWER trials and...

  • The Macroeconomic Consequences of Renouncing to Universal Access to Antiretroviral Treatment for HIV in Africa: A Micro-Simulation Model. Ventelou, Bruno; Arrighi, Yves; Greener, Robert; Lamontagne, Erik; Carrieri, Patrizia; Moatti, Jean-Paul // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Aim: Previous economic literature on the cost-effectiveness of antiretroviral treatment (ART) programs has been mainly focused on the microeconomic consequences of alternative use of resources devoted to the fight against the HIV pandemic. We rather aim at forecasting the consequences of...

  • The Macroeconomic Consequences of Renouncing to Universal Access to Antiretroviral Treatment for HIV in Africa: A Micro-Simulation Model. Ventelou, Bruno; Arrighi, Yves; Greener, Robert; Lamontagne, Erik; Carrieri, Patrizia; Moatti, Jean-Paul // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Aim: Previous economic literature on the cost-effectiveness of antiretroviral treatment (ART) programs has been mainly focused on the microeconomic consequences of alternative use of resources devoted to the fight against the HIV pandemic. We rather aim at forecasting the consequences of...

  • Association of Antiretroviral Therapy Adherence and Health Care Costs. Nachega, Jean B.; Leisegang, Rory; Bishai, David; Hoang Nguyen; Hislop, Michael; Cleary, Susan; Regensberg, Leon; Maartens, Gary // Annals of Internal Medicine;1/5/2010, Vol. 152 Issue 1, p18 

    Background: Antiretroviral therapy (ART) adherence predicts HIV disease progression and survival, but its effect on direct health care costs is unclear. Objective: To determine the effect of ART adherence on direct health care costs among adults in a resource-limited setting. Design: Cohort...

  • Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation: Report of 2 Cases. Henrich, Timothy J.; Hanhauser, Emily; Marty, Francisco M.; Sirignano, Michael N.; Keating, Sheila; Tzong-Hae Lee; Robles, Yvonne P.; Davis, Benjamin T.; Li, Jonathan Z.; Heisey, Andrea; Hill, Alison L.; Busch, Michael P.; Armand, Philippe; Soiffer, Robert J.; Altfeld, Marcus; Kuritzkes, Daniel R. // Annals of Internal Medicine;9/2/2014, Vol. 161 Issue 5, p319 

    Background: It is unknown whether the reduction in HIV-1 reservoirs seen after allogeneic hematopoietic stem cell transplantation (HSCT) with susceptible donor cells is sufficient to achieve sustained HIV-1 remission. Objective: To characterize HIV-1 reservoirs in blood and tissues and perform...

  • Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients. Perrone, Valentina; Cattaneo, Dario; Radice, Sonia; Sangiorgi, Diego; Federici, Augusto B.; Gismondo, Maria Rita; Medaglia, Massimo; Micheli, Valeria; Vimercati, Stefania; Pallone, Enza; Esposti, Luca Degli; Clementi, Emilio // ClinicoEconomics & Outcomes Research;2014, Vol. 6, p341 

    Background: Highly active antiretroviral therapy (HAART) has reduced morbidity and mortality in patients infected with human immunodeficiency virus (HIV). Studies have documented high interindividual variability in the pharmacokinetics of antiretroviral drugs, which may impair the success of...

  • A gift of hope to people with HIV. Snow, Tamsin // Nursing Standard;8/26/2009, Vol. 23 Issue 51, p22 

    South Africa has more people with HIV than any other country in the world. While antiretrovirals are free, there are other treatment costs. INSET: 'Give us training to help patients'.

  • Miscellaneous.  // Current Medical Literature: Leukemia & Lymphoma;2009, Vol. 17 Issue 4, p122 

    The article discusses stem cell transplantation-related studies. A study on high-dose therapy in a phase II trial for 50 antiretroviral therapy (ART)-treated patients who have relapsed or refractory autoimmune deficiency syndrome (AIDS)-related lymphoma (ARL) is supporting the use of autologous...

  • Perinatal HIV and Option B+. Theron, Gerhard // South African Journal of Obstetrics & Gynaecology;Oct2012, Vol. 18 Issue 3, p66 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the minimal access to antiretroviral therapy (ART), meta-analysis and systematic review of efavirenz (EFV) safety, and in vitro exposure of infants to antiretrovirals (ARVs).

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics